Rivoglitazone
Modify Date: 2025-08-27 01:06:07
Rivoglitazone structure
|
Common Name | Rivoglitazone | ||
|---|---|---|---|---|
| CAS Number | 185428-18-6 | Molecular Weight | 397.448 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 669.3±40.0 °C at 760 mmHg | |
| Molecular Formula | C20H19N3O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 358.6±27.3 °C | |
Use of RivoglitazoneRivoglitazone is a thiazolidinedione-derivative PPARγ agonist for the treatment of type 2 diabetes mellitus. |
| Name | 5-[[4-[(6-methoxy-1-methylbenzimidazol-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione |
|---|---|
| Synonym | More Synonyms |
| Description | Rivoglitazone is a thiazolidinedione-derivative PPARγ agonist for the treatment of type 2 diabetes mellitus. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 669.3±40.0 °C at 760 mmHg |
| Molecular Formula | C20H19N3O4S |
| Molecular Weight | 397.448 |
| Flash Point | 358.6±27.3 °C |
| Exact Mass | 397.109619 |
| PSA | 107.75000 |
| LogP | 2.95 |
| Vapour Pressure | 0.0±2.0 mmHg at 25°C |
| Index of Refraction | 1.683 |
| Rivoglitazone |
| 2,4-Thiazolidinedione, 5-[[4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]phenyl]methyl]- |
| Rivoglitazone [USAN] |
| 5-{4-[(6-Methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione |
| UNII:3A3N0634Q6 |
| Rivoglitazone [USAN:INN] |
| 5-[4-(6-Methoxy-1-methylbenzimidazol-2-yl-methoxy)benzyl]-thiazolidine-2,4-dione |
| (5R)-5-{4-[(6-methoxy-1-methyl-1H-benzimidazol-2-yl)methoxy]benzyl}1,3-thiazolidine-2,4-dione |
| UNII-3A3N0634Q6 |
| 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl] thiazolidine-2,4-dione |
| (5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl]thiazolidin-2,4-dione) |